Equities

Cenra Inc

3716:TAI

Cenra Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (TWD)37.90
  • Today's Change-0.10 / -0.26%
  • Shares traded75.22k
  • 1 Year change-19.36%
  • Beta--
Data delayed at least 20 minutes, as of Nov 22 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of TWD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
OPERATIONS
Net income391589659
Depreciation/depletion307286265
Non-Cash items(79)(172)(160)
Cash taxes paid, supplemental10698130
Cash interest paid, supplemental594336
Changes in working capital(25)(541)(81)
Total cash from operations602167696
INVESTING
Capital expenditures(247)(257)(208)
Other investing and cash flow items, total(85)(118)87
Total cash from investing(332)(375)(121)
FINANCING
Financing cash flow items(9.47)(3.28)2.45
Total cash dividends paid(238)(268)(298)
Issuance (retirement) of stock, net------
Issuance (retirement) of debt, net0.7962(474)
Total cash from financing(247)(209)(769)
NET CHANGE IN CASH
Foreign exchange effects(16)5.709.07
Net change in cash6.72(411)(185)
Net cash-begin balance/reserved for future use4388491,034
Net cash-end balance/reserved for future use445438849
SUPPLEMENTAL INCOME
Depreciation, supplemental307286265
Cash interest paid, supplemental594336
Cash taxes paid, supplemental10698130
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.